NYR
Click for more information
14.8% 5.2¢ nyrada inc.

Ann: Investor Presentation, page-4

  1. Bendunstan
    52 Posts.
    lightbulb Created with Sketch. 3
    clock Created with Sketch.
    16/08/24
    13:12
    Post #: 75238577
    So on success of the upcoming Walter Reed pre clinical study which is only few weeks away the department of defence has grants upto 24 million AUD for further progressing Nyrada drug through phase 2. Wow no wonder the CEO stated that “DOD will fund phase 2 trials reducing the need of dilution for TBI”


    https://hotcopper.com.au/data/attachments/6387/6387044-e6ad42c90bbc4a089f12df32824ee8df.jpg

    Last edited by Bendunstan: 16/08/24
    NYR Price at posting: 4.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The business of sport: Warren Tredrea's take on this week's news
right-arrow Created with Sketch.
NEWS Why are so many ASX explorers setting up shop in Saudi Arabia? + 8 stocks to watch
right-arrow Created with Sketch.
KPO KALiNA Power inks MOU for natgas powered data centres using carbon capture as AI energy use grows
right-arrow Created with Sketch.
NEWS Talking trends: The five shaping investment in 2024
right-arrow Created with Sketch.
JAV Javelin increases the resource of Coogee in WA by 158%
right-arrow Created with Sketch.
NEWS HotCopper's top watched; Oz banks cut saver interest; Kamala’s 28% corporate tax; AI’s back
right-arrow Created with Sketch.
watchlist Created with Sketch. Add NYR (ASX) to my watchlist
(20min delay)
Last
5.2¢ 		Change
-0.009(14.8%) 		Mkt cap ! $10.02M
Open High Low Value Volume
5.8¢ 5.8¢ 5.2¢ $12.47K 222.3K

Buyers (Bids)

No. Vol. Price($)
1 16000 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 165000 1
View Market Depth
Last trade - 14.05pm 26/08/2024 (20 minute delay) ?
NYR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.